OTC Markets OTCPK - Delayed Quote USD

Acutus Medical, Inc. (AFIB)

0.0453 +0.0002 (+0.44%)
At close: June 7 at 12:52 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Takeo Mukai CEO & CFO 385.01k -- 1981
Mr. Gary W. Doherty B.S. Senior Vice President of Finance 434.32k -- 1967

Acutus Medical, Inc.

2210 Faraday Avenue
Suite 100
Carlsbad, CA 92008
United States
442 232 6080 https://www.acutusmedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
230

Description

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Corporate Governance

Acutus Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 5, 2024 at 10:59 AM UTC - August 9, 2024 at 12:00 PM UTC

Acutus Medical, Inc. Earnings Date

Recent Events

May 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 3, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 25, 2024 at 12:00 AM UTC

DEFA14A: Proxy Statements

April 1, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

March 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 8, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 11, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 14, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers